RxSight (RXST) News
NASDAQ: RXSTHealth CareOphthalmic GoodsUSD
4.47-0.14 (-3.04%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RXST news summary
We found 8 recent headlines mentioning RxSight (RXST): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, RXST is down 3.04% at $4.47. The most recent story, "RxSight, Inc. to Present at the Piper Sandler Healthcare Conference", was published by GlobeNewswire on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest RxSight headlines
- RxSight, Inc. to Present at the Piper Sandler Healthcare ConferenceALISO VIEJO, Calif., Nov. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to present at the Piper Sandler 38 th Annual Healthcare Conference on…GlobeNewswire
- RxSight (RXST) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- RxSight, Inc. Reports Third Quarter 2026 Financial ResultsRxSight, Inc. reported total revenue of $24.6 million for the third quarter ended September 30, 2026, down 19% from the prior-year period, primarily reflecting ongoing competitive pressures. Revenue…Nasdaq
- RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue EstimatesRxSight (RXST) delivered earnings and revenue surprises of +27.59% and -10.56%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqRXST, GMED
- RxSight, Inc. Reports Third Quarter 2026 ResultsALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026.GlobeNewswire
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456…GlobeNewswire
- RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3ALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on…GlobeNewswire
- RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice…GlobeNewswire